Created at	Source	Raw Value	Validated value
Oct. 26, 2020, 11:31 p.m.	usa	Safety of the administration of allogeneic mesenchymal stem cells derived from adipose tissue assessed by Adverse Event Rate;Efficacy of the administration of allogeneic mesenchymal stem cells derived from adipose tissue assessed by Survival Rate	Safety of the administration of allogeneic mesenchymal stem cells derived from adipose tissue assessed by Adverse Event Rate;Efficacy of the administration of allogeneic mesenchymal stem cells derived from adipose tissue assessed by Survival Rate